Read next
News
German biotech AquaNab targets a $4 billion salmon farming problem with nanoantibody technology - secures funding to combat global sea lice challenge
With sea lice costing the aquaculture industry an estimated US$4 billion annually, the Hamburg-based company has developed AquaNabs, a first-of-its-kind…
Read article